An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
Clinical trial NCT03417037 · WITHDRAWN
Trial details
- NCT number
- NCT03417037
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-24
- Primary completion
- 2021-04-25
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.